Bluebird Ventures — Full Portfolio
13 tracked investments · listed companies and verified rows first
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inJosh Ofman(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)in
PartnerJeffrey Bird· solo GP
Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsDecheng CapitalDentsu VenturesFelicis Ventures+8 more
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)Jintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Casdin CapitalEuropean Innovation Council FundEuropean Investment Bank+5 more
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Founder, Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Russell J. Cox(President and CEO)
PartnerJeffrey Bird· solo GP
Co-investorsBroadview VenturesLongitude Capital
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries.
BiotechHealthtechMedical DevicesPalo Alto, US
Ravindra Majeti(Director)Irving Weissman(Director)Eric Jensen(Executive Officer)
BoardChristopher Schaepe(Director)Jeffrey Bird(Director)Dennis Henner(Director)
PartnerJeffrey Bird· solo GP
Co-investorsLightspeed Venture PartnersSofinnova Ventures
PartnerJeffrey Bird· solo GP
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Shankar Ramaswamy(Co-Founder, Chairman & CEO)inRoger Jeffs(Co-Founder & Vice Chairman)inFraser Wright(Scientific Co-Founder & Chief Gene Therapy Officer)inShankar Ramaswamy, M.D.(Founder)inMichele Stone(Chief Scientific Officer)inKatherine Eade(Chief Legal Officer)
PartnerJeffrey Bird· solo GP
Co-investorsPatient Square CapitalPremji InvestAmplo VenturesForesite CapitalJDRF T1D FundNarya Capital+2 more
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology.
BiotechHealthtech
William J. Dower(PhD)Michael C. Needels(PhD)Ronald W. Barrett(PhD)Joseph Leveque(MD, CEO)
PartnerJeffrey Bird· solo GP
Faction is a venture capital firm that invests in cryptocurrency and blockchain projects at the seed and series A stages, focusing on entrepreneurs building fundamental utility across the technology stack.
BiotechCrypto & Web3New York, US
Oren Harnevo(Executive Officer, Director)Ronald Bianchini, Jr.(Executive Officer, Director)Roneil Rumburg(Cofounder)Ohad Finkelstein(Director)Christina Calvaneso(Executive Officer)Brian Pozesky(Executive Officer)
PartnerJeffrey Bird· solo GP
Co-investorsAccelAdaverseAlephAxeleo CapitalBright Pixel CapitalCapitalG+36 more
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
PartnerJeffrey Bird· solo GP
Co-investors+ND CapitalARCH Venture Partners
Pharmaceutical company acquired by Alexion in 2020.
PartnerJeffrey Bird· solo GP
Co-investorsLightstone VenturesProspect Venture Partners
PartnerJeffrey Bird· solo GP
Co-investorsScientific Health DevelopmentTexas Ventures
BiotechHealthtechHouston, US
Reynolds, III M. Delagado(Director)Benjamin A Hertzog(Executive Officer, Director)Jason J Heuring(Executive Officer)Benjamin A. Hertzog(President & CEO)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
Co-investorsFannin Goldenrod HoldingsScientific Health Development
Pioneer in non-invasive prenatal testing, sold to Illumina in 2013.
PartnerJeffrey Bird· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.